Acrosoxacin

This page contains recent news articles, when available, and an overview of Acrosoxacin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Acrosoxacin (when available)

Pharmacology and use:
Acrosoxacin is a nonfluorinated quinolone antibiotic. Its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Acrosoxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. For the treatment of Bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients

Mechanism Of Action:
Acrosoxacin binds to and inhibits the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.

News Articles on Acrosoxacin

Brand Names/Synonyms:
Acrosoxacin is also known by the following brand names and/or synonyms:
Acrosoxacin; Eracine; Eradacil; Eradacin; ROS; Rosoxacin; Rosoxacin [Usan:Inn]; Rosoxacine [Inn-French]; Rosoxacino [Inn-Spanish]; Rosoxacinum [Inn-Latin]; Roxadyl; Winuron

Drug Category:
Acrosoxacin is categorized under the following by the FDA: Anti-Infective Agents

Dosage Forms:
Not Available

Absorption:
Not Available

Interactions:
Not Available

Chemical IUPAC Name:
1-ethyl-4-oxo-7-pyridin-4-yl-quinoline-3-carboxylic acid

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.